| 4% |
| 1.96% |
20% of the fund performance above the change from the benchmark portfolio over a one-year settlement period. Details available in the Fund's prospectus.
This is an advertising information. Past performance does not indicate future returns.
Try again later.
Module.Fund.Errors.ChartTextNoData.
| Performance* | ||
|---|---|---|
| Period | ESA Medicine & New Technology | |
| 1 month | -0.06% | |
| 3 months | 6.33% | |
| 6 months | 12.72% | |
| 12 months | -4.55% | |
| 36 months | -20.93% | |
| 60 months | -8.48% | |
| 120 months | -23.16% | |
| YTD | 7.66% | |
| * Performance of class A units, 18-04-2024 | ||
4 - high risk
Risk indicator is presented in accordance with the Key Information Document. The indicator is calculated based on the historical volatility of the fund's rates of return resulting from the implemented investment policy and may change in the future. Even the lowest risk category does not mean that the fund is risk-free. Other risk factors related to investing in the fund, which are not included in the indicator, are presented in the Key Information Document and the Fund's Prospectus.
Model allocation - up to 100% of subfund's portfolio invested in shares.
The subfund is designed for an investor who:
Transfer Agent
Pekao Financial Services Sp. z o.o.
Custodian
ING Bank Śląski S.A. w Katowicach
ESALIENS Medicine & New Technology Subfund invests from 60% to 100% of its assets in equity securities of companies listed on the regulated market. As a part of the investment objective, the Fund invests primarily in shares of companies whose activities are related to health protection or new technologies, as well as other types of investments.
The Fund may invest the Subfund's Assets in other investments, in particular debt securities or Money Market Instruments, in order to ensure the Subfund's liquidity and minimize the risk of impairment of the Shares in periods of downturn on the stock market.
The sub-fund is actively managed.
This is an advertising information. This material does not contain sufficient information to make an investment decision. The promoted investment means the purchase of participation units.
The fund do not guarantee that the investment objective or a specific investment result will be achieved. Before investing, you should read the Prospectus and the Key Information Documents. The Prospectus as well as the Key Information Documents include the data required to evaluate an investment, outline the risks connected with participation in the fund, and inform on the related costs, charges and taxes. Read the full text of the important information
go up
